(19)
(11) EP 1 551 856 A2

(12)

(88) Date of publication A3:
21.10.2004

(43) Date of publication:
13.07.2005 Bulletin 2005/28

(21) Application number: 03762177.8

(22) Date of filing: 27.06.2003
(51) International Patent Classification (IPC)7C07H 21/04, C12Q 1/00, C12Q 1/68, C12P 21/06, C12N 15/63
(86) International application number:
PCT/US2003/020410
(87) International publication number:
WO 2004/003159 (08.01.2004 Gazette 2004/02)
(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR
Designated Extension States:
AL LT LV MK

(30) Priority: 27.06.2002 US 391878 P

(71) Applicants:
  • Xenon Genetics, Inc.
    Burnaby,British Columbia V5G 4W8 (CA)
  • Warner-Lambert Company LLC
    Morris Plains,New Jersey 07950 (US)

(72) Inventors:
  • BROWNLIE, Alison, J.
    Vancouver, British Columbia V5L 2N4 (CA)
  • TAFURI,Sherrie, Rae
    Ann Arbor, MI 48103 (US)
  • BRINKMAN, Ryan, R.
    Vancouver, British Columbia V5Z 1B6 (CA)
  • CHAGNOVICH, Daniel
    Ann Arbor, MI 48103 (US)
  • CHATTERJEE, Aurobindo
    Ann Arbor, MI 48103 (US)
  • DONALDSON, Gary, C.
    Surrey, British Columbia V3S 9V2 (CA)
  • DUBE, Marie-Pierre
    Montreal, Quebec H2V 4A4 (CA)
  • GOLDBERG, Yigal, P.
    Vancouver, British Columbia V5Y 2A4 (CA)
  • JERVA, Leonard, F.
    Ann Arbor, MI 48103 (US)
  • LAFRENIER, Ronald, G.
    Verdun, Quebec H4H 1X5 (CA)
  • LUDWIG, Erwin
    Blaine, WA 98230 (US)
  • SAMUELS, Mark, E.
    Vancouver, British Columbia V5Y 3Y9 (CA)
  • WU, Chenyan
    Ann Arbor, MI 48105 (US)
  • HAYDEN, Michael, R.
    Vancouver, British Columbia V6R 1W9 (CA)

(74) Representative: Williams, Gareth Owen 
Marks & Clerk,66-68 Hills Road
Cambridge CB2 1LA
Cambridge CB2 1LA (GB)

   


(54) NOVEL THERAPEUTIC TARGET FOR TREATING VASCULAR DISEASES, DYSLIPIDEMIAS AND RELATED DISORDERS